An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
Conditions: C3G; IC-MPGN; C3 Glomerulopathy; C3 Glomerulonephritis; Complement 3 Glomerulopathy; Complement 3 Glomerulopathy (C3G); Complement 3 Glomerulonephritis; Dense Deposit Disease; DDD; Membranoproliferative Glomerulonephritis; Membranoproliferative Glomerul onephritis (MPGN); Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) Intervention: Drug: Pegcetacoplan Sponsor: Apellis Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2023 Category: Research Source Type: clinical trials
Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases
Conditions: Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Diabetic Nephropathies; Nephrosis, Lipoid; Hyperspectral Imaging Intervention: Diagnostic Test: Microscopic hyperspectral imaging system Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
